Samsara BioCapital, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001744967

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2024 · 42 positions · Total reported value $520.28M · Top-10 concentration 74.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.0% · 3 new · 7 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2024 13F filing, Samsara BioCapital, LLC disclosed 42 equity positions with a combined reported value of $520.28M. The filing implies a focused portfolio: its ten largest positions account for 74.3% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were CRGX ($81.47M), MLYS ($61.46M), SRRK ($54.38M). By sector, the heaviest allocations are Health Care 68.5%, Other 31.5%. Versus the prior quarter, allocation shifted toward Health Care (+3.2pp) and away from Other (-3.2pp).

Versus the prior quarter, Samsara BioCapital, LLC opened 3 new positions, trimmed 7 and fully exited 0, a turnover rate of 37.0% of positions. The portfolio's overlap with the prior quarter was 91% of names.

The largest new positions opened in Q3 2024 were ALMS ($34.89M), ARTV ($4.51M), BCAX ($891.45K).

Of the 1 positions fully exited versus the prior quarter, the largest were IGMS ($1.06M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • ALMS ALUMIS INC · $34.89M
  • ARTV ARTIVA BIOTHERAPEUTICS INC · $4.51M
  • BCAX BICARA THERAPEUTICS INC · $891.45K

Fully Exited (vs previous quarter)

  • IGMS IGM BIOSCIENCES INC · prev qtr: $1.06M

Insider Transactions (Form 4)

Latest Samsara BioCapital, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Samsara BioCapital, LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 27 positions worth $1.05B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • SEC registration: 801-113741 (status: Approved), registered 2018-07-27
  • Regulatory AUM (Form ADV): $2.17B as of 2026-10-28
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds

Portfolio Structure

  • 27 positions · $1.05B reported value (Q3 2026)
  • Top 10 holdings = 87.9% of reported value
  • Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 31.7%
  • Average position size: $38.95M

Sector Tilt

  • Health Care 91.8%
  • Industrials 8.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 3 new, 3 added, 7 reduced
  • 14 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 68.5%
Other 31.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 4.42M $81.47M 15.66%
15.66%
Hold
2 5.07M $61.46M 11.81%
11.81%
Hold
3 6.79M $54.38M 10.45%
10.45%
Hold
4 1.27M $53.20M 10.22%
10.22%
Hold
5 3.27M $34.89M 6.71%
6.71%
New
6 353.64K $29.53M 5.68%
5.68%
Reduce
7 1.21M $28.69M 5.51%
5.51%
Hold
8 3.77M $17.03M 3.27%
3.27%
Hold
9 2.61M $13.28M 2.55%
2.55%
Reduce
10 967.53K $12.69M 2.44%
2.44%
Hold
11 1.00M $12.55M 2.41%
2.41%
Hold
12 2.52M $12.44M 2.39%
2.39%
Hold
13 588.82K $11.27M 2.17%
2.17%
Hold
14 584.64K $11.00M 2.11%
2.11%
Add
15 850.00K $9.79M 1.88%
1.88%
Hold
16 172.65K $9.04M 1.74%
1.74%
Hold
17 1.56M $8.17M 1.57%
1.57%
Hold
18 2.20M $7.60M 1.46%
1.46%
Hold
19 2.44M $6.28M 1.21%
1.21%
Hold
20 6.13M $6.05M 1.16%
1.16%
Hold
21 195.22K $5.62M 1.08%
1.08%
Reduce
22 630.00K $4.85M 0.93%
0.93%
Hold
23 291.67K $4.51M 0.87%
0.87%
New
24 1.79M $3.84M 0.74%
0.74%
Hold
25 3.64M $3.82M 0.73%
0.73%
Hold
26 206.78K $2.81M 0.54%
0.54%
Hold
27 198.00K $2.26M 0.43%
0.43%
Hold
28 540.30K $2.09M 0.40%
0.40%
Hold
29 147.32K $2.05M 0.39%
0.39%
Reduce
30 202.35K $1.69M 0.32%
0.32%
Hold
31 799.27K $1.41M 0.27%
0.27%
Hold
32 22.53K $1.02M 0.20%
0.20%
Reduce
33 35.00K $891.45K 0.17%
0.17%
New
34 696.17K $800.60K 0.15%
0.15%
Hold
35 2.78M $714.53K 0.14%
0.14%
Hold
36 1.05M $679.85K 0.13%
0.13%
Hold
37 689.71K $159.60K 0.03%
0.03%
Hold
38 172.09K $112.41K 0.02%
0.02%
Hold
39 78.13K $78.12K 0.01%
0.01%
Hold
40 82.34K $66.57K 0.01%
0.01%
Hold
41 133.33K $13.05K 0.00%
0.00%
Hold
42 100.00K $1.03K 0.00%
0.00%
Hold

FAQ

What did Samsara BioCapital, LLC buy in 2024-Q3?

In its 2024-Q3 13F filing, Samsara BioCapital, LLC reported 42 equity positions worth $520.28M in aggregate; its largest disclosed positions were CRGX ($81.47M), MLYS ($61.46M), SRRK ($54.38M).

How large is Samsara BioCapital, LLC's portfolio?

Samsara BioCapital, LLC reported $520.28M of long equity holdings across 42 positions as of 2024-Q3. Top-10 holdings account for 74.3% of reported value.

What is Samsara BioCapital, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/samsara-biocapital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →